Mon, 04th Oct 2021 18:52
Oxford Nanopore Technologies PLC - genomics firm specialising in DNA sequencing and provider of rapid Covid-19 tests - Citigroup Global Markets Ltd exercises over-allotment option on 18.5 million shares from initial public offering at 425 pence each. Company is expected to receive GBP78.6 million in gross proceeds.
Current stock price: 600.15p, up 41% from IPO price
By Arvind Bhunjun; arvindbhunjun@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:
(Sharecast News) - Oxford Nanopore took the wraps off a "groundbreaking" study using its technology on Friday, shedding light on the measurement of hu...
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:
Oxford Nano (ONT)